Startup profile for Oura: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Oura funding, valuation and investors

Maker of Oura Ring and a connected health subscription; delayed its planned US IPO on September 29, 2026 after a $900M+ Series E at an approximately $11B private valuation in 2025.

Verified company research · funding, investors and latest developments

Keep track of Oura

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series E

More than $900M · October 14, 2025

Latest known valuation

Approximately $11B

Series E · October 14, 2025

Total disclosed equity funding

$1.1B

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Finland; US operations in San Francisco

Investors in latest funding

Lead: Fidelity Management & Research Company

Other: ICONIQ , Whale Rock , Atreides

Sources: latest funding · ouraring.com Last verified: 2026-10-29

Overview

Oura develops smart rings and a paid health platform covering sleep, readiness, activity and other biometric trends. It announced a $200M Series D in December 2024 at a $5.2B valuation, followed by more than $900M in Series E funding led by Fidelity Management & Research Company in October 2025 at roughly $11B.

In September 2026, Oura had publicly filed for a Nasdaq initial public offering and marketed a proposed $40–$44 per-share range, but postponed the offering on September 29 due to IPO-market uncertainty. The proposed roughly $13.5B market capitalization at the midpoint was not an actual public trading valuation. The company reported 5.7M paid members at the postponement, and media reported more than 6M on October 22.

Alumni Ventures lists Oura in its official portfolio; its specific check and entry round are not publicly established by these releases.

Why Oura is interesting

Oura is a useful case study in separating valuation types: its last announced private round priced the company around $11B, whereas a proposed September 2026 IPO price range implied a different public-market valuation that never became a trading price. Hardware sales and subscription retention determine the investment thesis.

Product & use cases

Oura Ring is a screenless wearable that measures biometric signals and surfaces sleep, activity, stress and readiness insights through the Oura app. A paid membership provides ongoing analysis and personalized features.

  • Sleep, recovery, activity and readiness tracking
  • Cycle and reproductive-health pattern awareness using wearable signals
  • Population and employee wellness insights through business partnerships

Key facts

  • Sep 29, 2026: delayed a proposed Nasdaq IPO; no shares were priced or traded as a result of that postponed offering.
  • Proposed IPO indicated 50M shares at $40–$44, or around $2.1B gross proceeds at midpoint; most shares were secondary.
  • Oct 14, 2025: more than $900M Series E led by Fidelity at approximately $11B private valuation.
  • Dec 19, 2024: $200M Series D at $5.2B private valuation.

Funding history (newest first)

Series E

2025-10-14 More than $900M Valuation: Approximately $11B
  • Fidelity Management & Research Company (lead)
  • ICONIQ (participant)
  • Whale Rock (participant)
  • Atreides (participant)

Source: Read source · ouraring.com

Series D

2024-12-19 $200M Valuation: $5.2B
  • Fidelity Management & Research Company (participant)
  • Dexcom (participant)

Source: Read source · ouraring.com

Investors in our directory

Funds linked from Oura's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Combining ring hardware, longitudinal biometric measurements and paid app subscriptions can increase engagement. Oura competes with major wearable platforms and must justify subscription value, hardware replacement cycles and data privacy.

IPO investors should separate Oura's $11B 2025 private mark from the implied value of a September 2026 proposed offering. A marketing range does not guarantee actual pricing, and 5.7M paid members are a company-reported activity figure, not the same as device unit sales or free cash flow.

  • Ultrahuman direct

    Smart-ring competitor; differentiated subscription strategy and feature mix.

  • Samsung Galaxy Ring direct

    Ring wearable sold through a major smartphone ecosystem.

  • Whoop adjacent

    Subscription-based recovery and performance wearable with different form factor.

  • Apple Watch incumbent

    Smartwatch ecosystem with sleep and health sensing, but a different device format.

Industries

Market / IPO context

IPO status: filed

Note: Last company-announced private mark: about $11B in October 2025. A proposed September 2026 IPO midpoint implied roughly $13.5B but listing was postponed on September 29, 2026; the proposal did not establish a market capitalization.

Editorial / static context — not a live quote.

FAQs about Oura

Practical answers founders, operators, and investors typically search for.

No. Oura filed for a proposed US IPO but postponed the offering on September 29, 2026. As of October 29, it remains private; a proposed ticker or price is not a traded public share.
Oura cited IPO-market uncertainty despite strong interest. Reporting noted investors' pricing sensitivity and a large proportion of existing-holder shares in the offering.
Oura's October 2025 Series E valued it at about $11B. A proposed September 2026 IPO midpoint implied approximately $13.5B but was postponed, so it is not an achieved public market value.
Oura announced a $200M Series D in December 2024 and more than $900M in Series E financing in October 2025. These were separate financings; the proposed 2026 IPO would have been another transaction, but it did not close.
Alumni Ventures lists Oura as a portfolio company, but the Series E release names Fidelity, ICONIQ, Whale Rock and Atreides. AV's specific investment round or check amount cannot be inferred from the portfolio listing.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.